Bebtelovimab: considerations for global access to treatments during a rapidly evolving pandemic. Nichols RM, Deveau C, Upadhyaya H. Lancet Infect Dis 2022;22:1531.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nichols RM, Deveau C, Upadhyaya H. Bebtelovimab: considerations for global access to treatments during a rapidly evolving pandemic. Lancet Infect Dis 2022;22:1531.
PMID: 36174596